Dinan T G
Dept. of Psychological Medicine, St. Bartholomew's Hospital, London, United Kingdom.
Life Sci. 1996;58(20):1683-94. doi: 10.1016/0024-3205(96)00066-5.
That serotonin (5HT) is involved in regulating hypothalamic-pituitary- adrenal axis (HPA) function has long been recognized. A variety of drugs including precursors of 5HT such as 5HTP, drugs which release 5HT such as fenfluramine and drugs which act directly on 5HT receptors such as ipsapirone increase cortisol and ACTH concentrations. There is a general assumption that such stimulation occurs at a hypothalamic level. However, our increasing understanding of the complex interplay between 5HT and the HPA raises questions as to the validity of this simple model. An increasing volume of experimental research indicates that 5HT can act directly on the adrenal gland and possibly on the anterior pituitary as well. These findings have major implications for the interpretation of neuroendocrine studies of 5HT conducted in psychiatric conditions, such as depression.
长期以来,人们一直认识到血清素(5-羟色胺,5HT)参与调节下丘脑-垂体-肾上腺轴(HPA)功能。包括5HT前体(如5-羟色氨酸,5HTP)、释放5HT的药物(如芬氟拉明)以及直接作用于5HT受体的药物(如伊沙匹隆)在内的多种药物都会增加皮质醇和促肾上腺皮质激素(ACTH)的浓度。人们普遍认为这种刺激发生在下丘脑水平。然而,我们对5HT与HPA之间复杂相互作用的日益了解,对这个简单模型的有效性提出了质疑。越来越多的实验研究表明,5HT可直接作用于肾上腺,也可能直接作用于垂体前叶。这些发现对解释在诸如抑郁症等精神疾病中进行的5HT神经内分泌研究具有重要意义。